Réaction #5686

ord-51fadc04c6db458b83e946b701fe0f2a

Équation de réaction

Cl
hydrochloric acid
Cc1ccc(S(=O)(=O)OCCC2CCCN(C(=O)c3ccc(NC(=O)c4ccccc4C)cc3C)c3ccc(Cl)cc32)cc1
5-[2-(p-toluenesulfonyloxy)ethyl]-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
[I-].[Na+]
sodium iodide
CC(=O)N1CCNCC1
4-acetylpiperazine
CC(=O)N1CCN(CCC2CCCN(C(=O)c3ccc(NC(=O)c4ccccc4C)cc3C)c3ccc(Cl)cc32)CC1.Cl
5-[2-(4-acetyl-1-piperazinyl)ethyl]-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride
Rendement 121.5%

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    TempératureThe mixture is heated at 50° C. for 2 hours
  2. 2
    workup.WAITfurther at 60° C. for 3 hours
  3. 3
    Autrethe aqueous layer is collected
  4. 4
    Extractionextracted with dichloromethane
  5. 5
    LavageThe dichloromethane layer is washed with water
  6. 6
    Autredried
  7. 7
    workup.DISTILLATIONthe solvent is distilled off
  8. 8
    workup.ADDITIONTo the resulting residue is added hydrochloric acid/ethanol

Mode opératoire

To a solution of 5-[2-(p-toluenesulfonyloxy)ethyl]-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine (0.25 g) in dry dimethylformamide (20 ml) are added sodium iodide (0.178 g) and 4-acetylpiperazine (0.152 g), and the mixture is stirred at room temperature for one hour. The mixture is heated at 50° C. for 2 hours, and further at 60° C. for 3 hours. To the reaction solution are added 1N-hydrochloric acid and diethyl ether, and the aqueous layer is collected and neutralized with saturated aqueous sodium hydrogen carbonate solution, and extracted with dichloromethane. The dichloromethane layer is washed with water, dried, and the solvent is distilled off. To the resulting residue is added hydrochloric acid/ethanol to give 5-[2-(4-acetyl-1-piperazinyl)ethyl]-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride (150 mg) as colorless amorphous.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US05244898uspto-grants-1993_09